FOURTH QUARTER 2023 FINANCIAL HIGHLIGHTS
- Total revenues increased $25.5 million, or 8.1%, to $339.2
million in Q4 2023 from $313.7 million in Q4 2022.
- Net income was $2.8 million in Q4 2023 compared to $17.1
million in Q4 2022. Results for Q4 2023 include a non-cash
unrealized loss of $19.4 million, net of tax, related to the
company's investment in a hospital-at-home company([1]).
- Adjusted EBITDA(7), a non-GAAP measure, increased $2.3 million,
or 5.9%, to $41.4 million in Q4 2023 from $39.0 million in Q4
2022.
- Diluted earnings per share was $0.15 in Q4 2023 compared to
$0.85 in Q4 2022. Results for Q4 2023 include the non-cash
unrealized loss related to the company's investment in a
hospital-at-home company, which had an unfavorable impact of $1.00
on diluted earnings per share in Q4 2023(1).
- Adjusted diluted earnings per share(7), a non-GAAP measure,
increased $0.17, or 15.2%, to $1.29 in Q4 2023 from $1.12 in Q4
2022.
FULL YEAR 2023 FINANCIAL HIGHLIGHTS AND 2024 GUIDANCE
- Total revenues increased $229.6 million, or 20.3%, to $1.36
billion for 2023 from $1.13 billion for 2022.
- Revenues within all segments increased; led by Healthcare, the
company's largest segment, which increased 26.0% to $674.0 million
for 2023, compared to $535.0 million for 2022.
- Net income was $62.5 million for 2023, compared to $75.6
million for 2022. Results for 2023 and 2022 include a non-cash
unrealized loss of $19.4 million, net of tax, and a non-cash
unrealized gain of $19.8 million, net of tax, respectively, related
to the company's investment in a hospital-at-home company(1).
- Adjusted EBITDA(7), a non-GAAP measure, increased $36.5
million, or 27.9%, to $167.3 million for 2023 from $130.8 million
for 2022.
- Adjusted EBITDA as a percentage of revenues(7), a non-GAAP
measure, increased 70 basis points to 12.3% for 2023 from 11.6% for
2022.
- Diluted earnings per share was $3.19 for 2023, compared to
$3.64 for 2022. Results for 2023 and 2022 included the non-cash
unrealized loss and non-cash unrealized gain related to the
company's investment in a hospital-at-home company, which had an
unfavorable impact of $0.99 and a favorable impact of $0.96 on
diluted earnings per share in 2023 and 2022, respectively(1).
- Adjusted diluted earnings per share(7), a non-GAAP measure,
increased $1.48, or 43.1%, to $4.91 for 2023 from $3.43 for
2022.
- Net cash provided by operating activities increased $49.9
million, or 58.4%, to $135.3 million for 2023, compared to $85.4
million for 2022.
- Huron returned $123.6 million to shareholders in 2023 by
repurchasing 1.5 million shares of the company's common stock.
- Huron provides full year 2024 guidance, including revenue
expectations in a range of $1.46 billion to $1.54 billion.
OTHER HIGHLIGHTS
- Huron amended its credit facility to include a $275 million
term loan, which increases the company's capacity for investment
and return to shareholders.
- Huron released its 2023 Corporate Social Responsibility Report,
which reiterates the company's commitment to shaping a more
sustainable future.
- Huron was named a “Best Place to Work” by Glassdoor, one of the
world's largest and most influential communities for workplace
conversations. Huron secured the 32nd position out of 100 on
Glassdoor’s Best Places to Work US Large list, including a 4.5
rating.
- Huron was named a “Best Place to Work for LGBTQ Equality” by
the Human Rights Campaign (HRC) Foundation. Huron scored a perfect
100 on the HRC Foundation’s 2023-2024 Corporate Equality Index
(CEI), which evaluates employers on corporate policies, culture and
social responsibility initiatives, equal employment opportunities
and benefits.
(1) In 2019, the Company invested $5 million in a
hospital-at-home company as a strategic investment in a valued
client relationship that annually produces meaningful
implementation projects for Huron's Healthcare segment. As of
December 31, 2023, the investment's carrying value was $7.4
million, reflecting a net unrealized gain of $2.4 million on the
investment since inception. Huron's ownership percentage in this
hospital-at-home company is less than 5%.
Global professional services firm Huron (NASDAQ: HURN) today
announced financial results for the fourth quarter and full year
ended December 31, 2023.
“Driven by strong growth across all three operating segments, we
achieved record revenues and expanded our operating margins for the
third consecutive year. Our fourth quarter performance was
consistent with our expectations, culminating in record financial
performance for the full year 2023,” said Mark Hussey, chief
executive officer and president of Huron. “These results are only
possible because of our incredibly talented team and their
commitment to making a lasting impact on our clients and our
business, while supporting one another in our highly collaborative
culture.”
“Our financial performance demonstrates the foundation we have
established to continue delivering on our medium-term investor
objectives. Our deep industry expertise and leading market
positions in healthcare and education, our expanding presence in
commercial industries, and our rapidly growing portfolio of digital
capabilities position us well to fulfill ongoing market demand and
to meet or exceed our medium-term financial objectives for low
double-digit revenue growth, increased profitability margins, and
higher earnings per share,” added Hussey.
FOURTH QUARTER 2023 RESULTS
Revenues increased $25.5 million, or 8.1%, to $339.2 million for
the fourth quarter of 2023, compared to $313.7 million for the
fourth quarter of 2022. This revenue growth reflects continued
strength in demand in the Digital capability across all segments,
highlighted by 19% growth of the Digital capability within the
Healthcare segment; and continued growth in the Healthcare and
Education segments' Consulting and Managed Services capability.
Net income was $2.8 million for the fourth quarter of 2023,
compared to $17.1 million for the same quarter last year. Results
for the fourth quarter of 2023 include a non-cash unrealized loss
of $19.4 million, net of tax, related to the decrease in fair value
of the company's investment in a hospital-at-home company(1).
Diluted earnings per share was $0.15 for the fourth quarter of
2023, compared to $0.85 for the fourth quarter of 2022. The
non-cash unrealized loss related to the investment had an
unfavorable impact of $1.00 on diluted earnings per share in the
fourth quarter of 2023.
Fourth quarter 2023 earnings before interest, taxes,
depreciation and amortization ("EBITDA")(7) was $12.7 million,
compared to $34.5 million in the same prior year period. Results
for the fourth quarter of 2023 include a non-cash unrealized
pre-tax loss of $26.3 million related to the company's strategic
investment in a hospital-at-home company(1).
In addition to using EBITDA to evaluate the company’s financial
performance, management uses other non-GAAP financial measures,
which exclude the effect of the following items (in thousands):
Three Months Ended
December 31,
2023
2022
Amortization of intangible assets
$
2,017
$
2,702
Restructuring charges
$
2,165
$
4,953
Other gains, net
$
(242
)
$
(159
)
Transaction-related expenses
$
55
$
—
Unrealized loss on preferred stock
investment
$
26,262
$
—
Tax effect of adjustments
$
(8,018
)
$
(1,986
)
Foreign currency transaction losses
(gains), net
$
440
$
(246
)
Adjusted EBITDA(7) increased $2.3 million, or 5.9%, to $41.4
million, or 12.2% of revenues, in the fourth quarter of 2023,
compared to $39.0 million, or 12.4% of revenues, in the same
quarter last year. Adjusted net income(7) increased $2.5 million,
or 11.0%, to $25.1 million, or $1.29 per diluted share, for the
fourth quarter of 2023, compared to $22.6 million, or $1.12 per
diluted share, for the same quarter in 2022.
The number of revenue-generating professionals(2) increased
14.2% to 5,519 as of December 31, 2023 from 4,832 as of December
31, 2022. The utilization rate(6) of the company's Consulting
capability was 76.8% during the fourth quarter 2023, compared to
80.6% during the same period last year. The utilization rate(6) for
the company's Digital capability increased to 80.5% during the
fourth quarter 2023, compared to 69.4% during the same period last
year.
FULL YEAR 2023 RESULTS
Revenues increased $229.6 million, or 20.3%, to $1.36 billion
for full year 2023, compared to $1.13 billion for full year 2022.
This revenue growth was highlighted by 22.6% growth in the
Consulting and Managed Services capability and 17.3% growth in the
Digital capability in the aggregate across all industries; and
reflects the company's focus on accelerating growth in the
healthcare and education industries and growing its presence in
commercial industries.
Net income was $62.5 million for full year 2023, compared to
$75.6 million for full year 2022. Results for full year 2023
include a non-cash unrealized loss of $19.4 million, net of tax,
related to the company's investment in a hospital-at-home company;
and results for full year 2022 include a non-cash unrealized gain
of $19.8 million, net of tax, related to the same investment(1).
Diluted earnings per share was $3.19 for full year 2023, compared
to $3.64 for full year 2022. The non-cash unrealized loss related
to the investment had an unfavorable impact of $0.99 on diluted
earnings per share in 2023, and the non-cash unrealized gain had a
favorable impact of $0.96 on diluted earnings per share in
2022.
EBITDA(7) for full year 2023 was $129.1 million, and included a
non-cash unrealized pre-tax loss of $26.3 million related to the
company's investment in a hospital-at-home company. EBITDA for full
year 2022 was $148.7 million and included a non-cash unrealized
pre-tax gain of $27.0 million, related to the same investment in a
hospital-at-home company(1).
In addition to using EBITDA to evaluate the company’s financial
performance, management uses other non-GAAP financial measures,
which exclude the effect of the following items (in thousands):
Twelve Months Ended
December 31,
2023
2022
Amortization of intangible assets
$
8,219
$
11,198
Restructuring charges
$
11,550
$
9,909
Other gains, net
$
(444
)
$
(193
)
Transaction-related expenses
$
357
$
50
Unrealized loss (gain) on preferred stock
investment
$
26,262
$
(26,964
)
Tax effect of adjustments
$
(12,175
)
$
1,590
Foreign currency transaction losses
(gains), net
$
476
$
(655
)
Adjusted EBITDA(7) increased $36.5 million, or 27.9%, to $167.3
million, or 12.3% of revenues, for full year 2023, compared to
$130.8 million, or 11.6% of revenues, for full year 2022. Adjusted
net income(7) increased $25.1 million, or 35.3%, to $96.2 million,
or $4.91 per diluted share, for full year 2023, compared to $71.1
million, or $3.43 per diluted share, for full year 2022.
The number of revenue-generating professionals(2) increased
14.2% to 5,519 as of December 31, 2023 from 4,832 as of December
31, 2022. The utilization rate(6) of the company's Consulting
capability increased to 76.6% for full year 2023, compared to 75.2%
for full year 2022. The utilization rate(6) of the company's
Digital capability increased to 75.3% for full year 2023, compared
to 71.0% for full year 2022.
Additionally, in 2023, Huron repurchased 1,461,815 shares of the
company's common stock for $123.6 million, representing 7.4% of our
common stock outstanding as of December 31, 2022.
OPERATING INDUSTRIES
The company’s year-to-date 2023 revenues by operating segment as
a percentage of total company revenues are as follows: Healthcare
(49%); Education (32%); and Commercial (19%). Financial results by
operating industry are included in the attached schedules and in
Huron's forthcoming Annual Report on Form 10-K filing for the year
ended December 31, 2023.
OUTLOOK FOR 2024
Based on currently available information, the company provided
guidance for full year 2024 revenues before reimbursable expenses
to a range of $1.46 billion to $1.54 billion. The company also
anticipates adjusted EBITDA as a percentage of revenues in a range
of 12.8% to 13.3% and non-GAAP adjusted diluted earnings per share
in a range of $5.35 to $5.95.
2024 TERM LOAN
On February 26, 2024, Huron amended its senior secured credit
facility to include a $275 million term loan in addition to the
existing $600 million revolving credit facility, both of which
mature on November 15, 2027. The amendment to include the term loan
was led by Bank of America, N.A., as administrative agent, JPMorgan
Chase Bank, N.A. and PNC Bank, National Association, and provides
additional flexibility to support Huron's growth strategy and
balanced approach to capital deployment. The proceeds from the term
loan will be used to reduce borrowings under the company's
revolving credit facility, which increases the company's capacity
for investment.
Additional details regarding the term loan are included in
Huron’s Current Report on Form 8-K filed with the Securities and
Exchange Commission. The Form 8-K is available on Huron’s website
at http://ir.huronconsultinggroup.com.
FOURTH QUARTER 2023 WEBCAST
The company will host a webcast to discuss its financial results
today, February 27, 2024, at 5:00 p.m. Eastern Time, 4:00 p.m.
Central Time. The conference call is being webcast by Notified and
can be accessed from Huron's website at
http://ir.huronconsultinggroup.com. A replay will be available
approximately two hours after the conclusion of the webcast and for
90 days thereafter.
USE OF NON-GAAP FINANCIAL MEASURES(7)
In evaluating the company’s financial performance and outlook,
management uses EBITDA, adjusted EBITDA, adjusted EBITDA as a
percentage of revenues, adjusted net income, and adjusted diluted
earnings per share, which are non-GAAP measures. Management uses
these non-GAAP financial measures to gain an understanding of the
company's comparative operating performance (when comparing such
results with previous periods or forecasts). These non-GAAP
financial measures are used by management in their financial and
operating decision making because management believes they reflect
the company's ongoing business in a manner that allows for
meaningful period-to-period comparisons. Management also uses these
non-GAAP financial measures when publicly providing their business
outlook, for internal management purposes, and as a basis for
evaluating potential acquisitions and dispositions. Management
believes that these non-GAAP financial measures provide useful
information to investors and others in understanding and evaluating
Huron’s current operating performance and future prospects in the
same manner as management does, if they so choose, and in comparing
in a consistent manner Huron’s current financial results with
Huron’s past financial results. Investors should recognize that
these non-GAAP measures might not be comparable to similarly titled
measures of other companies. These measures should be considered in
addition to, and not as a substitute for or superior to, any
measure of performance, cash flows or liquidity prepared in
accordance with accounting principles generally accepted in the
United States.
Management has provided its outlook regarding adjusted EBITDA
and adjusted diluted earnings per share, both of which are non-GAAP
financial measures and exclude certain charges. Management has not
reconciled these non-GAAP financial measures to the corresponding
GAAP financial measures because guidance for the various
reconciling items is not provided. Management is unable to provide
guidance for these reconciling items because they cannot determine
their probable significance, as certain items are outside of the
company's control and cannot be reasonably predicted since these
items could vary significantly from period to period. Accordingly,
reconciliations to the corresponding GAAP financial measures are
not available without unreasonable effort.
ABOUT HURON
Huron is a global professional services firm that collaborates
with clients to put possible into practice by creating sound
strategies, optimizing operations, accelerating digital
transformation, and empowering businesses and their people to own
their future. By embracing diverse perspectives, encouraging new
ideas and challenging the status quo, we create sustainable results
for the organizations we serve. Learn more at
www.huronconsultinggroup.com.
Statements in this press release that are not historical in
nature, including those concerning the company’s current
expectations about its future results, are “forward-looking”
statements as defined in Section 21E of the Securities Exchange Act
of 1934, as amended, and the Private Securities Litigation Reform
Act of 1995. Forward-looking statements are identified by words
such as “may,” “should,” “expects,” “provides,” “anticipates,”
“assumes,” “can,” “will,” “meets,” “could,” “likely,” “intends,”
“might,” “predicts,” “seeks,” “would,” “believes,” “estimates,”
“plans,” “continues,” “goals,” “guidance,” or “outlook” or similar
expressions. These forward-looking statements reflect the company's
current expectations about future requirements and needs, results,
levels of activity, performance, or achievements. Some of the
factors that could cause actual results to differ materially from
the forward-looking statements contained herein include, without
limitation: failure to achieve expected utilization rates, billing
rates, and the necessary number of revenue-generating
professionals; inability to expand or adjust our service offerings
in response to market demands; our dependence on renewal of
client-based services; dependence on new business and retention of
current clients and qualified personnel; failure to maintain
third-party provider relationships and strategic alliances;
inability to license technology to and from third parties; the
impairment of goodwill; various factors related to income and other
taxes; difficulties in successfully integrating the businesses we
acquire and achieving expected benefits from such acquisitions;
risks relating to privacy, information security, and related laws
and standards; and a general downturn in market conditions. These
forward-looking statements involve known and unknown risks,
uncertainties, and other factors, including, among others, those
described under “Item 1A. Risk Factors” in Huron's Annual Report on
Form 10-K for the year ended December 31, 2023 that may cause
actual results, levels of activity, performance or achievements to
be materially different from any anticipated results, levels of
activity, performance, or achievements expressed or implied by
these forward-looking statements. The company disclaims any
obligation to update or revise any forward-looking statements as a
result of new information or future events, or for any other
reason.
HURON CONSULTING GROUP
INC.
CONSOLIDATED STATEMENTS OF
OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS)
(In thousands, except per
share amounts)
(Unaudited)
Three Months Ended
December 31,
Twelve Months Ended
December 31,
2023
2022
2023
2022
Revenues and reimbursable
expenses:
Revenues
$
339,228
$
313,711
$
1,362,060
$
1,132,455
Reimbursable expenses
10,777
7,472
36,695
26,506
Total revenues and reimbursable
expenses
350,005
321,183
1,398,755
1,158,961
Operating expenses:
Direct costs (exclusive of depreciation
and amortization included below)
234,342
216,033
942,697
785,881
Reimbursable expenses
10,524
7,422
36,766
26,671
Selling, general and administrative
expenses
66,833
60,495
257,488
209,381
Restructuring charges
2,165
4,953
11,550
9,909
Depreciation and amortization
6,285
6,781
24,906
27,359
Total operating expenses
320,149
295,684
1,273,407
1,059,201
Operating income
29,856
25,499
125,348
99,760
Other income (expense), net:
Interest expense, net of interest
income
(4,427
)
(4,130
)
(19,573
)
(11,883
)
Other income (expense), net
(23,661
)
2,001
(21,880
)
20,700
Total other income (expense), net
(28,088
)
(2,129
)
(41,453
)
8,817
Income before taxes
1,768
23,370
83,895
108,577
Income tax expense
(1,064
)
6,286
21,416
33,025
Net income
$
2,832
$
17,084
$
62,479
$
75,552
Earnings per share:
Net income per basic share
$
0.15
$
0.88
$
3.32
$
3.73
Net income per diluted share
$
0.15
$
0.85
$
3.19
$
3.64
Weighted average shares used in
calculating earnings per share:
Basic
18,510
19,470
18,832
20,249
Diluted
19,389
20,159
19,601
20,746
Comprehensive income (loss):
Net income
$
2,832
$
17,084
$
62,479
$
75,552
Foreign currency translation adjustments,
net of tax
795
(157
)
512
(1,890
)
Unrealized gain (loss) on investment, net
of tax
4,735
(3,428
)
7,811
(6,146
)
Unrealized gain (loss) on cash flow
hedging instruments, net of tax
(3,381
)
257
(3,615
)
9,315
Other comprehensive income (loss)
2,149
(3,328
)
4,708
1,279
Comprehensive income
$
4,981
$
13,756
$
67,187
$
76,831
HURON CONSULTING GROUP
INC.
CONSOLIDATED BALANCE
SHEETS
(In thousands, except share
and per share amounts)
(Unaudited)
December 31,
2023
December 31,
2022
Assets
Current assets:
Cash and cash equivalents
$
12,149
$
11,834
Receivables from clients, net
162,566
147,852
Unbilled services, net
190,869
141,781
Income tax receivable
6,385
960
Prepaid expenses and other current
assets
28,491
26,057
Total current assets
400,460
328,484
Property and equipment, net
23,728
26,107
Deferred income taxes, net
2,288
1,554
Long-term investments
75,414
91,194
Operating lease right-of-use assets
24,131
30,304
Other non-current assets
92,336
73,039
Intangible assets, net
18,074
23,392
Goodwill
625,711
624,966
Total assets
$
1,262,142
$
1,199,040
Liabilities and stockholders’
equity
Current liabilities:
Accounts payable
$
10,074
$
14,254
Accrued expenses and other current
liabilities
33,087
27,268
Accrued payroll and related benefits
225,921
171,723
Current maturities of operating lease
liabilities
11,032
10,530
Deferred revenues
22,461
21,909
Total current liabilities
302,575
245,684
Non-current liabilities:
Deferred compensation and other
liabilities
35,665
33,614
Long-term debt
324,000
290,000
Operating lease liabilities, net of
current portion
38,850
45,556
Deferred income taxes, net
28,160
32,146
Total non-current liabilities
426,675
401,316
Commitments and contingencies
Stockholders’ equity
Common stock; $0.01 par value; 500,000,000
shares authorized; 21,316,441 and 22,507,159 shares issued,
respectively
212
223
Treasury stock, at cost, 2,852,296 and
2,711,712 shares, respectively
(142,136
)
(137,556
)
Additional paid-in capital
236,962
318,706
Retained earnings
415,027
352,548
Accumulated other comprehensive income
22,827
18,119
Total stockholders’ equity
532,892
552,040
Total liabilities and stockholders’
equity
$
1,262,142
$
1,199,040
HURON CONSULTING GROUP
INC.
CONSOLIDATED STATEMENTS OF
CASH FLOWS
(In thousands)
(Unaudited)
Twelve Months Ended
December 31,
2023
2022
Cash flows from operating
activities:
Net income
$
62,479
$
75,552
Adjustments to reconcile net income to
cash flows from operating activities:
Depreciation and amortization
24,938
27,359
Non-cash lease expense
6,321
6,369
Lease-related impairment charges
6,248
211
Share-based compensation
45,697
30,971
Amortization of debt discount and issuance
costs
769
1,169
Allowances for doubtful accounts
421
141
Deferred income taxes
(6,182
)
18,784
Gain on sale of property and equipment,
excluding transaction costs
(64
)
(1,111
)
Change in fair value of contingent
consideration liabilities
(490
)
(359
)
Change in fair value of preferred stock
investment
26,262
(26,964
)
Other, net
—
6
Changes in operating assets and
liabilities, net of acquisitions and divestiture:
(Increase) decrease in receivables from
clients, net
(15,046
)
(25,847
)
(Increase) decrease in unbilled services,
net
(49,051
)
(51,359
)
(Increase) decrease in current income tax
receivable / payable, net
(5,139
)
7,673
(Increase) decrease in other assets
(6,535
)
2,532
Increase (decrease) in accounts payable
and other liabilities
(6,948
)
(13,466
)
Increase (decrease) in accrued payroll and
related benefits
51,022
32,770
Increase (decrease) in deferred
revenues
560
969
Net cash provided by operating
activities
135,262
85,400
Cash flows from investing
activities:
Purchases of property and equipment
(9,444
)
(12,547
)
Investment in life insurance policies
(3,074
)
(872
)
Distributions from life insurance
policies
2,956
3,377
Purchases of businesses
(1,613
)
(3,448
)
Capitalization of internally developed
software costs
(25,742
)
(11,752
)
Proceeds from note receivable
154
154
Proceeds from sale of property and
equipment
111
4,753
Divestiture of business
—
207
Net cash used in investing activities
(36,652
)
(20,128
)
Cash flows from financing
activities:
Proceeds from exercises of stock
options
2,524
1,421
Shares redeemed for employee tax
withholdings
(10,536
)
(7,795
)
Share repurchases
(122,757
)
(120,393
)
Proceeds from bank borrowings
354,000
314,000
Repayments of bank borrowings
(320,000
)
(256,780
)
Payments for debt issuance costs
(58
)
(2,686
)
Deferred payments on business
acquisition
(1,500
)
(1,875
)
Net cash used in financing activities
(98,327
)
(74,108
)
Effect of exchange rate changes on
cash
32
(111
)
Net increase (decrease) in cash and cash
equivalents
315
(8,947
)
Cash and cash equivalents at beginning of
the period
11,834
20,781
Cash and cash equivalents at end of the
period
$
12,149
$
11,834
HURON CONSULTING GROUP
INC.
SEGMENT OPERATING RESULTS AND
OTHER OPERATING DATA
(Unaudited)
Three Months Ended
December 31,
Percent
Increase
(Decrease)
Twelve Months Ended
December 31,
Percent
Increase
(Decrease)
Segment and Consolidated Operating
Results (in thousands):
2023
2022
2023
2022
Healthcare:
Revenues
$
171,995
$
153,330
12.2
%
$
673,989
$
534,999
26.0
%
Operating income
$
44,606
$
39,786
12.1
%
$
172,900
$
131,227
31.8
%
Segment operating margin
25.9
%
25.9
%
25.7
%
24.5
%
Education:
Revenues
$
103,779
$
96,601
7.4
%
$
429,663
$
359,835
19.4
%
Operating income
$
21,986
$
20,076
9.5
%
$
99,098
$
78,924
25.6
%
Segment operating margin
21.2
%
20.8
%
23.1
%
21.9
%
Commercial:
Revenues
$
63,454
$
63,780
(0.5
)%
$
258,408
$
237,621
8.7
%
Operating income
$
14,231
$
11,743
21.2
%
$
54,202
$
50,025
8.3
%
Segment operating margin
22.4
%
18.4
%
21.0
%
21.1
%
Total Huron:
Revenues
$
339,228
$
313,711
8.1
%
$
1,362,060
$
1,132,455
20.3
%
Reimbursable expenses
10,777
7,472
44.2
%
36,695
26,506
38.4
%
Total revenues and reimbursable
expenses
$
350,005
$
321,183
9.0
%
$
1,398,755
$
1,158,961
20.7
%
Segment operating income
$
80,823
$
71,605
12.9
%
$
326,200
$
260,176
25.4
%
Items not allocated at the segment
level:
Other operating expenses
45,199
40,083
12.8
%
174,762
136,459
28.1
%
Restructuring charges
1,323
923
43.3
%
8,204
3,686
122.6
%
Depreciation and amortization
4,445
5,100
(12.8
)%
17,886
20,271
(11.8
)%
Total operating income
29,856
25,499
17.1
%
125,348
99,760
25.6
%
Other income (expense), net
(28,088
)
(2,129
)
N/M
(41,453
)
8,817
N/M
Income before taxes
$
1,768
$
23,370
(92.4
)%
$
83,895
$
108,577
(22.7
)%
Other Operating Data:
Number of revenue-generating
professionals by segment (at period end) (2):
Healthcare
2,270
1,890
20.1
%
2,270
1,890
20.1
%
Education
1,788
1,579
13.2
%
1,788
1,579
13.2
%
Commercial (3)
1,461
1,363
7.2
%
1,461
1,363
7.2
%
Total
5,519
4,832
14.2
%
5,519
4,832
14.2
%
Revenue by capability:
Consulting and Managed Services (4)
$
192,883
$
183,638
5.0
%
$
782,020
$
637,994
22.6
%
Digital
146,345
130,073
12.5
%
580,040
494,461
17.3
%
Total
$
339,228
$
313,711
8.1
%
$
1,362,060
$
1,132,455
20.3
%
Number of revenue-generating
professionals by capability (at period end)(2):
Consulting and Managed Services (5)
2,648
2,294
15.4
%
2,648
2,294
15.4
%
Digital
2,871
2,538
13.1
%
2,871
2,538
13.1
%
Total
5,519
4,832
14.2
%
5,519
4,832
14.2
%
Utilization rate by capability
(6):
Consulting
76.8
%
80.6
%
76.6
%
75.2
%
Digital
80.5
%
69.4
%
75.3
%
71.0
%
____________________
(2)
Consists of our full-time
consultants who generate revenues based on the number of hours
worked; full-time equivalents, which consists of coaches and their
support staff within the culture and organizational excellence
solution, consultants who work variable schedules as needed by
clients, and full-time employees who provide software support and
maintenance services to clients; and our Healthcare managed
services employees who provide revenue cycle billing, collections
insurance verification and change integrity services to
clients.
(3)
The majority of our
revenue-generating professionals within our Commercial segment can
provide services across all of our industries, including healthcare
and education.
(4)
Managed Services capability
revenues within our Healthcare segment was $16.3 million and $20.1
million for the three months ended December 31, 2023 and 2022,
respectively; and $70.1 million and $67.6 million for the year
ended December 31, 2023 and 2022, respectively.
Managed Services capability
revenues within our Education segment was $4.9 million and $4.4
million for the three months ended December 31, 2023 and 2022,
respectively; and $19.5 million and $15.7 million for the year
ended December 31, 2023 and 2022, respectively.
(5)
The number of Managed Services
revenue-generating professionals within our Healthcare segment was
924 and 715 as of December 31, 2023 and 2022, respectively.
The number of Managed Services
revenue-generating professionals within our Education segment was
103 and 106 as of December 31, 2023 and 2022, respectively.
(6)
Utilization rate is calculated by
dividing the number of hours our billable consultants worked on
client assignments during a period by the total available working
hours for these billable consultants during the same period.
Available hours are determined by the standard hours worked by each
billable consultant, adjusted for part-time hours, and U.S.
standard work weeks. Available working hours exclude local country
holidays and vacation days. Utilization rates are presented for our
revenue-generating professionals who primarily bill on an hourly
basis. We have not presented utilization rates for our Managed
Services professionals as most of the revenues generated by these
employees are not billed on an hourly basis.
HURON CONSULTING GROUP
INC.
RECONCILIATION OF NET
INCOME
TO ADJUSTED EARNINGS BEFORE
INTEREST, TAXES, DEPRECIATION AND AMORTIZATION (7)
(In thousands)
(Unaudited)
Three Months Ended
December 31,
Twelve Months Ended
December 31,
2023
2022
2023
2022
Revenues
$
339,228
$
313,711
$
1,362,060
$
1,132,455
Net income
$
2,832
$
17,084
$
62,479
$
75,552
Add back:
Income tax expense (benefit)
(1,064
)
6,286
21,416
33,025
Interest expense, net of interest
income
4,427
4,130
19,573
11,883
Depreciation and amortization
6,489
6,995
25,672
28,233
Earnings before interest, taxes,
depreciation and amortization (EBITDA) (7)
12,684
34,495
129,140
148,693
Add back:
Restructuring charges
2,165
4,953
11,550
9,909
Other gains, net
(242
)
(159
)
(444
)
(193
)
Transaction-related expenses
55
—
357
50
Unrealized loss (gain) on preferred stock
investment
26,262
—
26,262
(26,964
)
Foreign currency transaction losses
(gains), net
440
(246
)
476
(655
)
Adjusted EBITDA (7)
$
41,364
$
39,043
$
167,341
$
130,840
Adjusted EBITDA as a percentage of
revenues (7)
12.2
%
12.4
%
12.3
%
11.6
%
HURON CONSULTING GROUP
INC.
RECONCILIATION OF NET INCOME
TO ADJUSTED NET INCOME (7)
(In thousands, except per
share amounts)
(Unaudited)
Three Months Ended
December 31,
Twelve Months Ended
December 31,
2023
2022
2023
2022
Net income
$
2,832
$
17,084
$
62,479
$
75,552
Weighted average shares -
diluted
19,389
20,159
19,601
20,746
Diluted earnings per share
$
0.15
$
0.85
$
3.19
$
3.64
Add back:
Amortization of intangible assets
2,017
2,702
8,219
11,198
Restructuring charges
2,165
4,953
11,550
9,909
Other gains, net
(242
)
(159
)
(444
)
(193
)
Transaction-related expenses
55
—
357
50
Unrealized loss (gain) on preferred stock
investment
26,262
—
26,262
(26,964
)
Tax effect of adjustments
(8,018
)
(1,986
)
(12,175
)
1,590
Total adjustments, net of tax
22,239
5,510
33,769
(4,410
)
Adjusted net income (7)
$
25,071
$
22,594
$
96,248
$
71,142
Adjusted weighted average shares -
diluted
19,389
20,159
19,601
20,746
Adjusted diluted earnings per share
(7)
$
1.29
$
1.12
$
4.91
$
3.43
(7)
In evaluating the company’s
financial performance and outlook, management uses earnings before
interest, taxes, depreciation and amortization (“EBITDA”), adjusted
EBITDA, adjusted EBITDA as a percentage of revenues, adjusted net
income, and adjusted diluted earnings per share, which are non-GAAP
measures. Management uses these non-GAAP financial measures to gain
an understanding of the company's comparative operating performance
(when comparing such results with previous periods or forecasts).
These non-GAAP financial measures are used by management in their
financial and operating decision making because management believes
they reflect the company's ongoing business in a manner that allows
for meaningful period-to-period comparisons. Management also uses
these non-GAAP financial measures when publicly providing the
company's business outlook, for internal management purposes, and
as a basis for evaluating potential acquisitions and dispositions.
Management believes that these non-GAAP financial measures provide
useful information to investors and others in understanding and
evaluating Huron’s current operating performance and future
prospects in the same manner as management does, if they so choose,
and in comparing in a consistent manner Huron’s current financial
results with Huron’s past financial results. Investors should
recognize that these non-GAAP measures might not be comparable to
similarly titled measures of other companies. These measures should
be considered in addition to, and not as a substitute for or
superior to, any measure of performance, cash flows or liquidity
prepared in accordance with accounting principles generally
accepted in the United States.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240227454000/en/
MEDIA CONTACT Allie Bovis abovis@hcg.com INVESTOR
CONTACT John D. Kelly investor@hcg.com
Huron Consulting (NASDAQ:HURN)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
Huron Consulting (NASDAQ:HURN)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025